• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[抗肿瘤药物的治疗失败。细胞外和细胞内原因]

[Therapeutic failure of antineoplastic agents. Extracellular and cellular causes].

作者信息

Hofsli E

机构信息

Institutt for kreftforskning, Kreftavdelingen, Regionsykehuset i Trondheim.

出版信息

Tidsskr Nor Laegeforen. 1991 Jan 10;111(1):37-40.

PMID:2000585
Abstract

Chemotherapy plays an important role in the treatment of cancer. However, the drug regimens used today can only offer a cure to a small fraction of cancer patients. The article reviews the factors that limit the effect of chemotherapeutic treatment of cancer. The major cause of failure of chemotherapeutic treatment is the presence of resistant tumour cells. In addition to the various changes that may occur in tumour cells, various other factors may limit the "effective concentration" of a drug delivered to the site of the tumour, and thereby affect the overall clinical response to therapy.

摘要

化疗在癌症治疗中发挥着重要作用。然而,如今使用的药物方案仅能治愈一小部分癌症患者。本文综述了限制癌症化疗效果的因素。化疗失败的主要原因是存在耐药肿瘤细胞。除了肿瘤细胞可能发生的各种变化外,其他各种因素可能会限制输送到肿瘤部位的药物“有效浓度”,从而影响治疗的总体临床反应。

相似文献

1
[Therapeutic failure of antineoplastic agents. Extracellular and cellular causes].[抗肿瘤药物的治疗失败。细胞外和细胞内原因]
Tidsskr Nor Laegeforen. 1991 Jan 10;111(1):37-40.
2
[Resistance to chemotherapeutic agents in the treatment of cancer. Emphasizing the multiresistant phenotype].癌症治疗中对化疗药物的耐药性。着重探讨多药耐药表型
Tidsskr Nor Laegeforen. 1991 Aug 20;111(19):2423-7.
3
Cancer chemotherapy.
Ann Ital Med Int. 1990 Jul-Sep;5(3 Pt 3):288-95.
4
Multidrug resistance in cancer therapy: role of the microenvironment.癌症治疗中的多药耐药性:微环境的作用。
Curr Opin Investig Drugs. 2003 Dec;4(12):1416-21.
5
Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies.转移性疾病的发病机制:对当前治疗及新治疗策略开发的启示
Cancer Treat Rep. 1986 Jan;70(1):183-99.
6
The role of pharmacogenetics in chemotherapy: modulation of tumour response and host toxicity.
Cancer Surv. 1993;17:79-104.
7
Combination chemotherapy--theory and practice.联合化疗——理论与实践
Semin Oncol. 1977 Jun;4(2):227-53.
8
[Principles of drug therapy of malignant tumors: the role of malignant progression in the choice of effective drugs].[恶性肿瘤药物治疗原则:恶性进展在有效药物选择中的作用]
Orv Hetil. 1999 May 30;140(22):1245-9.
9
Evolving concepts in the systemic drug therapy of breast cancer.乳腺癌全身药物治疗的概念演变
Semin Oncol. 1997 Aug;24(4 Suppl 10):S10-3-S10-10.
10
Intravenous administration of antineoplastic drugs: review of basics and what's new in 2009.
J Infus Nurs. 2009 Sep-Oct;32(5):276-85. doi: 10.1097/NAN.0b013e3181b42ea1.